213 related articles for article (PubMed ID: 24213507)
21. Cytogenetic aberrations and DNA ploidy in soft tissue sarcoma. A Southwest Oncology Group Study.
Mohamed AN; Zalupski MM; Ryan JR; Koppitch F; Balcerzak S; Kempf R; Wolman SR
Cancer Genet Cytogenet; 1997 Nov; 99(1):45-53. PubMed ID: 9352795
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
23. DNA flow cytometry of canine mammary tumours: the relationship of DNA ploidy and S-phase fraction to clinical and histological features.
Pérez Alenza MD; Rutteman GR; Kuipers-Dijkshoorn NJ; Peña L; Montoya A; Misdorp W; Cornelisse CJ
Res Vet Sci; 1995 May; 58(3):238-43. PubMed ID: 7659848
[TBL] [Abstract][Full Text] [Related]
24. Cellular proliferation and nuclear ploidy assessments augment established prognostic factors in predicting malignancy in testicular Leydig cell tumours.
McCluggage WG; Shanks JH; Arthur K; Banerjee SS
Histopathology; 1998 Oct; 33(4):361-8. PubMed ID: 9822927
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas.
Golouh R; Bracko M; Novak J
Mod Pathol; 1996 Sep; 9(9):919-24. PubMed ID: 8878024
[TBL] [Abstract][Full Text] [Related]
26. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
27. Relationship between histologic grade and cytofluorometric cellular DNA and RNA content in primary bone tumors.
Takeshita H; Kusuzaki K; Kuzuhara A; Tsuji Y; Ashihara T; Gebhardt MC; Mankin HJ; Springfield DS; Hirasawa Y
Anticancer Res; 2001; 21(2B):1271-7. PubMed ID: 11396198
[TBL] [Abstract][Full Text] [Related]
28. DNA flow analysis of soft tissue tumors.
Kreicbergs A; Tribukait B; Willems J; Bauer HC
Cancer; 1987 Jan; 59(1):128-33. PubMed ID: 3024798
[TBL] [Abstract][Full Text] [Related]
29. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas.
Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T
Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365
[TBL] [Abstract][Full Text] [Related]
30. DNA-aneuploidy in rhabdomyosarcomas as compared with other sarcomas of childhood and adolescence.
Molenaar WM; Dam-Meiring A; Kamps WA; Cornelisse CJ
Hum Pathol; 1988 May; 19(5):573-9. PubMed ID: 3371982
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric DNA ploidy analysis of feline mammary tumors.
Minke JM; Cornelisse CJ; Stolwijk JA; Kuipers-Dijkshoorn NJ; Rutteman GR; Misdorp W
Cancer Res; 1990 Jul; 50(13):4003-7. PubMed ID: 2354449
[TBL] [Abstract][Full Text] [Related]
32. DNA ploidy of spindle cell soft-tissue tumors and its relationship to histology and clinical outcome.
Agarwal V; Greenebaum E; Wersto R; Koss LG
Arch Pathol Lab Med; 1991 Jun; 115(6):558-62. PubMed ID: 2039341
[TBL] [Abstract][Full Text] [Related]
33. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
[TBL] [Abstract][Full Text] [Related]
34. [Flow cytometric analysis of DNA from 98 cases of soft tissue tumors and its clinical significance].
Li S
Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):281-4, 318. PubMed ID: 2086097
[TBL] [Abstract][Full Text] [Related]
35. Genomic instability and DNA ploidy are linked to DNA copy number aberrations of 8p23 and 22q11.23 in gastric cancers.
Kawauchi S; Furuay T; Uchiyama T; Adachi A; Okada T; Nakao M; Oga A; Uchida K; Sasaki K
Int J Mol Med; 2010 Sep; 26(3):333-9. PubMed ID: 20664948
[TBL] [Abstract][Full Text] [Related]
36. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors.
Kroese MC; Rutgers DH; Wils IS; Van Unnik JA; Roholl PJ
Cancer; 1990 Apr; 65(8):1782-8. PubMed ID: 2156603
[TBL] [Abstract][Full Text] [Related]
37. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
[TBL] [Abstract][Full Text] [Related]
38. Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas.
Nasir L; Rutteman GR; Reid SW; Schulze C; Argyle DJ
Cancer Lett; 2001 Dec; 174(1):83-9. PubMed ID: 11675155
[TBL] [Abstract][Full Text] [Related]
39. Bone metastases: prognostic applications of cytometric DNA analysis.
Herget GW; Smolka W; Adler CP; Uhl M; Kreuz PC; Knoller SM
Anal Quant Cytol Histol; 2004 Aug; 26(4):217-22. PubMed ID: 15457674
[TBL] [Abstract][Full Text] [Related]
40. DNA aneuploidy, S-phase fraction, nuclear p53 positivity, and survival in non-small-cell lung carcinoma.
Dalquen P; Moch H; Feichter G; Lehmann M; Solèr M; Stulz P; Jordan P; Torhorst J; Mihatsch MJ; Sauter G
Virchows Arch; 1997 Sep; 431(3):173-9. PubMed ID: 9334838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
